Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation
Autor Philip A. Rea, Mark V. Pauly, Lawton R. Burnsen Limba Engleză Hardback – 31 ian 2018
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 330.93 lei 6-8 săpt. | |
Cambridge University Press – 31 ian 2018 | 330.93 lei 6-8 săpt. | |
Hardback (1) | 681.72 lei 6-8 săpt. | |
Cambridge University Press – 31 ian 2018 | 681.72 lei 6-8 săpt. |
Preț: 681.72 lei
Preț vechi: 765.99 lei
-11% Nou
Puncte Express: 1023
Preț estimativ în valută:
130.48€ • 135.63$ • 108.08£
130.48€ • 135.63$ • 108.08£
Carte tipărită la comandă
Livrare economică 05-19 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781107130906
ISBN-10: 1107130905
Pagini: 554
Ilustrații: 5 b/w illus. 39 colour illus. 3 tables
Dimensiuni: 158 x 235 x 29 mm
Greutate: 1.01 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
ISBN-10: 1107130905
Pagini: 554
Ilustrații: 5 b/w illus. 39 colour illus. 3 tables
Dimensiuni: 158 x 235 x 29 mm
Greutate: 1.01 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
Cuprins
Preface; 1. Discoveries now and then: shifting incentives and expectations Mark V. Pauly, Philip A. Rea and Lawton R. Burns; 2. Pharma trends: not what they seem Kyle Myers and Mark V. Pauly; 3. Profit maximizing drug firms: models and myths Vicki Chen and Mark V. Pauly; Transitional note: introduction to the case studies; 4. The Statins: cholesterols 'penicillins' Philip A. Rea; 5. ACE inhibitors: kidney clamps, snake venoms and peptidomimetics Alec Ren and Philip A. Rea; 6. Angioplasty: catheters, guidewires and balloons Simon Basseyn, Sourav Bose, Lawton R. Burns and Chris Groskaufmanis; 7. Hepatitis C: when cures and prices go viral Stephen Goldstein, Peter M. Stokes, Connie Lu and Philip A. Rea; 8. Alzheimer's: America's new most feared disease Julian Pei, John Q. Trojanowski, Peter M. Stokes, Katherine Clark, Mark V. Pauly and Philip A. Rea; 9. Metformin: to the brink and back Anderson Y. Tien and Philip A Rea; 10. Medical genomics: personalized precision Marc S. Williams; 11. Gleevec: from broken chromosomes to precision cancer therapy Vivek Nimgaonkar and Philip A. Rea; 12. Regeneron: agility, resilience and balance Lawton R. Burns, Alex Rosen, Steven Nichtberger and Philip A. Rea; 13. Avastin and Lucentis: both for eyesight in hindsight Osama Ahmed, Mark V. Pauly, Peter M. Stokes and Philip A. Rea; 14. CAR T-cell therapy: cures for ALL and more? Stephen Goldstein, Amy Le and Philip A. Rea; 15. Organizing discovery: wild ducks nested in multilevel ecosystems Lawton R. Burns and Philip A. Rea; 16. Can government help with the creatively unexpected? Mark V. Pauly, Lawton R. Burns and Philip A. Rea; Appendix: three key elements in the discovery process: historical and philosophical antecedents Mark V. Pauly; Index.
Recenzii
'The authors captured the magic of the biomedical industry from the inception of an idea through translational studies that lead to a product that can transform lives. Case studies illustrate the importance of scientific understanding, long periods of experimentation, willingness to take risks. This book is a 'must read' for anyone who wants to better understand drug discovery.' P. Roy Vagelos, Chairman, Regeneron Pharmaceuticals, Inc
'This new study by Philip A. Rea, Mark V. Pauly, and Lawton R. Burns provides useful information and insightful analyses of the biomedical innovation process.' Henry Grabowski, Professor Emeritus of Economics, Duke University, North Carolina
'This new study by Philip A. Rea, Mark V. Pauly, and Lawton R. Burns provides useful information and insightful analyses of the biomedical innovation process.' Henry Grabowski, Professor Emeritus of Economics, Duke University, North Carolina
Notă biografică
Descriere
Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.